AACR Clinical Trial Results

Objective response rates from clinical trials reported in AACR (2022-2024)

Note: these results are automatically extracted from congress literature with large language models. Please report any data quality issues to [email protected]

Filter by cancer type

Breast cancer

Lung cancer

Melanoma

Pancreatic cancer

Colorectal cancer

CLL

Gastric cancer

Ovarian cancer

Peritoneal cancer

Pleural mesothelioma

Fallopian tube cancer

AACR year

Filter by patient subgroup

2024

Other years

Background

The results shown above are from AACR abstracts for clinical trial results with an objective response rate (ORR) endpoint from 2022, 2023 and 2024 (published on April 5, 2024). The data is extracted automatically using large language models, allowing you to quickly evaluate relevant results published in AACR. Please visit the original abstract to evaluate the results further. If you would like to learn more or report a data quality issue, please contact us at [email protected].